Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.83M Buy
82,293
+1,171
+1% +$154K 1.12% 30
2025
Q4
$11M Buy
81,122
+236
+0.3% +$33.9K 1.17% 27
2025
Q3
$11.9M Sell
80,886
-487
-0.6% -$67.5K 1.29% 25
2025
Q2
$10.5M Buy
81,373
+1,476
+2% +$179K 1.18% 28
2025
Q1
$9.54M Buy
79,897
+1,158
+1% +$144K 1.12% 29
2024
Q4
$9.14M Buy
78,739
+2,775
+4% +$351K 1.01% 35
2024
Q3
$10.3M Buy
75,964
+670
+0.9% +$89.6K 1.13% 32
2024
Q2
$10.2M Sell
75,294
-2,707
-3% -$368K 1.19% 29
2024
Q1
$10.1M Buy
78,001
+452
+0.6% +$54.6K 1.16% 30
2023
Q4
$8.87M Buy
77,549
+251
+0.3% +$25.1K 1.11% 34
2023
Q3
$7.04M Buy
77,298
+546
+0.7% +$56.3K 0.97% 35
2023
Q2
$8.64M Buy
76,752
+2,558
+3% +$271K 1.15% 32
2023
Q1
$7.77M Buy
74,194
+1,345
+2% +$140K 1.12% 32
2022
Q4
$8.05M Sell
72,849
-955
-1% -$100K 1.19% 31
2022
Q3
$6.45M Buy
73,804
+2,840
+4% +$258K 0.98% 38
2022
Q2
$5.55M Buy
70,964
+2,516
+4% +$208K 0.71% 52
2022
Q1
$5.84M Sell
68,448
-81
-0.1% -$7.76K 0.62% 54
2021
Q4
$8.22M Buy
68,529
+1,525
+2% +$189K 0.8% 44
2021
Q3
$8.29M Buy
67,004
+1,773
+3% +$228K 0.89% 39
2021
Q2
$7.83M Sell
65,231
-3,703
-5% -$423K 0.85% 44
2021
Q1
$7.25M Buy
68,934
+1,015
+1% +$103K 0.82% 46
2020
Q4
$6.91M Buy
67,919
+7,152
+12% +$672K 0.82% 43
2020
Q3
$5.11M Buy
60,767
+15,345
+34% +$1.19M 0.68% 45
2020
Q2
$2.95M Sell
45,422
-318
-0.7% -$21K 0.43% 59
2020
Q1
$2.98M Buy
+45,740
New +$3.6M 0.52% 56

Other funds holding XYL

Middleton & Co's XYL Position: Q1 2026 in Review

Middleton & Co increased its Xylem (XYL) stake by 1.4% in Q1 2026, buying an estimated $154K and bringing the position to 82,293 shares worth $9.83M. The position accounts for 1.12% of the portfolio, ranked #30.

Middleton & Co first reported a position in XYL in Q1 2020 and has held it in 25 quarters since. The position peaked at $11.9M in Q3 2025. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Middleton & Co held 82,293 shares of Xylem worth $9.83M as of Q1 2026.
  • Middleton & Co bought 1,171 Xylem shares in Q1 2026, an estimated $154K.
  • Xylem made up 1.12% of Middleton & Co's portfolio in Q1 2026, its #30 holding.
  • Middleton & Co first reported a position in Xylem in Q1 2020 and has held it in 25 quarters since.
  • Middleton & Co's Xylem position peaked at $11.9M in Q3 2025.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.